The Association between Mutations Detected in Tissue and Plasma from Patients with Colorectal Adenoma and Adenocarcinoma
Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=52294#.VI-er8nQrzE
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=52294#.VI-er8nQrzE
Author(s)
1Department of Oncology, Vejle Hospital, Vejle, Denmark.
2Department of Pathology, Vejle Hospital, Vejle, Denmark.
3Department of Biochemistry, Vejle Hospital, Vejle, Denmark.
4Department of Pathology, Copenhagen University Hospital, Copenhagen, Denmark.
5Department of Surgical Gastroenterology, Copenhagen University Hospital, Copenhagen, Denmark.
2Department of Pathology, Vejle Hospital, Vejle, Denmark.
3Department of Biochemistry, Vejle Hospital, Vejle, Denmark.
4Department of Pathology, Copenhagen University Hospital, Copenhagen, Denmark.
5Department of Surgical Gastroenterology, Copenhagen University Hospital, Copenhagen, Denmark.
Most colorectal cancers
evolve through an adenoma-carcinoma sequence with mutations in the KRAS/BRAF
pathway as an early event. Mutation analyses are usually performed on tissue
samples, but during the last couple of years the same analysis in blood has
been facilitated. Our aim was to investigate the correlation between BRAF/KRAS
mutations in tissue and plasma from colorectal adenomas and adenocarcinomas.
Out of 22 patients with adenomas 10 had a mutation in the tissue, but no
mutations were detected in the plasma. In 10 of 26 adenocarcinomas a mutation
was found in the tumor and in four of these, the mutation was also detected in
the plasma. Our results confirm previous findings that mutated DNA in plasma
can be detected in approximately 50% of
non-metastasized adenocarcinomas. The difference between adenomas and
adenocarcinomas suggests that appearance of mutated DNA in plasma associates
with invasion.
KEYWORDS
Cite this paper
Larsen, C. , Lindebjerg, J. , Andersen, R. ,
Pallisgaard, N. , Holck, S. , Jakobsen, A. and Nielsen, H. (2014) The
Association between Mutations Detected in Tissue and Plasma from
Patients with Colorectal Adenoma and Adenocarcinoma. Journal of Cancer Therapy, 5, 1399-1401. doi: 10.4236/jct.2014.514141.
| [1] | Fearon, E.R. and Vogelstein, B. (1990) A Genetic Model for Colorectal Tumorigenesis. Cell, 61, 759-767. http://dx.doi.org/10.1016/0092-8674(90)90186-I |
| [2] | Rey, J.W., Kiesslich, R. and Hoffman, A. (2014) New Aspects of Modern Endoscopy. World Journal of Gastrointestinal Endoscopy, 6, 334-344. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4133412&tool=pmcentrez&rendertype=abstract http://dx.doi.org/10.4253/wjge.v6.i8.334 |
| [3] |
Taly, V., Pekin, D., El Abed, A.
and Laurent-Puig, P. (2012) Detecting Biomarkers with Microdroplet
Technology. Trends in Molecular Medicine, 18, 405-416. http://dx.doi.org/10.1016/j.molmed.2012.05.001 |
| [4] | Peyssonnaux, C. and Eychène, A. (2001) The Raf/MEK/ERK Pathway: New Concepts of Activation. Biology of the Cell, 93, 53-62. http://dx.doi.org/10.1016/S0248-4900(01)01125-X |
| [5] | Vogelstein, B., Fearon, E.R., Hamilton, S.R., Kern, S.E., Preisinger, A.C., Leppert, M., et al. (1988) Genetic Alterations during Colorectal-Tumor Development. New England Journal of Medicine, 319, 525-532. http://dx.doi.org/10.1056/NEJM198809013190901 |
| [6] | Andersen, R.F., et al. (2015) Improved Sensitivity of Circulating Tumor DNA Measurement Using Short PCR Amplicons. Clinica Chimica Acta, 439, 97-101. http://dx.doi.org/10.1016/j.cca.2014.10.011 |
| [7] | Velho, S., Moutinho, C., Cirnes, L., Albuquerque, C., Hamelin, R., Schmitt, F., et al. (2008) BRAF, KRAS and PIK3CA Mutations in Colorectal Serrated Polyps and Cancer: Primary or Secondary Genetic Events in Colorectal Carcinogenesis? BMC Cancer, 8, 255. http://dx.doi.org/10.1186/1471-2407-8-255 |
| [8] | Wynter, C.V.A., Walsh, M.D., Higuchi, T., Leggett, B.A., Young, J. and Jass, J.R. (2004) Methylation Patterns Define Two Types of Hyperplastic Polyp Associated with Colorectal Cancer. Gut, 53, 573-580. http://dx.doi.org/10.1136/gut.2003.030841 |
| [9] |
O’Brien, M.J., Yang, S., Mack,
C., Xu, H., Huang, C.S., Mulcahy, E., et al. (2006) Comparison of
Microsatellite Instability, CpG Island Methylation Phenotype, BRAF and
KRAS Status in Serrated Polyps and Traditional Adenomas Indicates
Separate Pathways to Distinct Colorectal Carcinoma End Points. American
Journal of Surgical Pathology, 30, 1491-1501. http://dx.doi.org/10.1097/01.pas.0000213313.36306.85 eww141216lx |
评论
发表评论